Teva Pharmaceutical Industries Ltd- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Teva Pharmaceutical Industries Ltd 公司

Teva Pharmaceutical Industries Ltd 是一家总部位于以色列的制药公司。该公司通过三个部门运营：北美、欧洲和国际市场。每个业务部门管理其所在地区的整个产品组合，包括仿制药、特种产品和非处方 (OTC) 产品。除了这三个部门之外，该公司还开展其他业务，主要是向第三方销售活性药物成分 (API)、某些合同制造服务以及通过其附属公司 Medis 向其他制药公司提供产品组合的对外授权平台。

公司简介

公司代码TEVA

公司名称Teva Pharmaceutical Industries Ltd

上市日期Jan 01, 1951

成立日期1944

CEOMr. Richard D. Francis

员工数量33892

证券类型Ordinary Share

年结日Jan 01

公司地址124 Dvora Hanevi'a St.

城市TEL AVIV-YAFO

上市交易所Tel Aviv Stock Exchange

国家Israel

邮编6944020

电话97239148213

网址https://www.tevapharm.com/

公司代码TEVA

上市日期Jan 01, 1951

成立日期1944

公司高管

名称

名称/职务

职务

持股

持股变动

Ms. Christine (Chris) Fox

Executive Vice President - U.S. Commercial

14.28K

--

Prof. Varda Shalev

Independent Director

12.87K

--

Mr. David R. McAvoy

Executive Vice President, Chief Legal Officer

11.91K

--

Mr. Evan Lippman

Executive Vice President - Business Development

--

Mr. Placid Jover

Executive Vice President, Chief Human Resources Officer

--

Mr. Richard Daniell

Executive Vice President - European Commercial

--

Mr. Eliyahu Sharon (Eli) Kalif

Chief Financial Officer, Executive Vice President

--

Mr. Matthew Shields

Executive Vice President - Teva Global Operations

--

Mr. Chen Lichtenstein

Independent Director

--

Dr. Sol J. Barer, Ph.D.

Independent Chairman of the Board

--

名称

名称/职务

职务

持股

持股变动

Ms. Christine (Chris) Fox

Executive Vice President - U.S. Commercial

14.28K

--

Prof. Varda Shalev

Independent Director

12.87K

--

Mr. David R. McAvoy

Executive Vice President, Chief Legal Officer

11.91K

--

Mr. Evan Lippman

Executive Vice President - Business Development

--

Mr. Placid Jover

Executive Vice President, Chief Human Resources Officer

--

Mr. Richard Daniell

Executive Vice President - European Commercial

--

收入明细

单位: USD更新时间: 4月6日周日

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Generic products

9.46B

57.19%

AUSTEDO

1.69B

10.20%

Anda

1.54B

9.28%

Other

1.38B

8.32%

AJOVY

507.00M

3.06%

Other

1.98B

11.94%

地区USD

名称

营收

占比

United States

8.03B

48.56%

Europe

5.10B

30.85%

International Markets

2.46B

14.89%

Other

944.00M

5.71%

业务

地区

业务USD

名称

营收

占比

Generic products

9.46B

57.19%

AUSTEDO

1.69B

10.20%

Anda

1.54B

9.28%

Other

1.38B

8.32%

AJOVY

507.00M

3.06%

Other

1.98B

11.94%

股东统计

更新时间: 12 小时前

持股股东

股东类型

持股股东

股东统计

占比

Fidelity Management & Research Company LLC

6.63%

Clal Insurance Enterprises Holdings Ltd.

3.40%

Ion Asset Management Israel Ltd

3.20%

BlackRock Institutional Trust Company, N.A.

2.89%

Menora Mivtachim Insurance Ltd.

2.47%

Other

81.42%

持股股东

股东统计

占比

Fidelity Management & Research Company LLC

6.63%

Clal Insurance Enterprises Holdings Ltd.

3.40%

Ion Asset Management Israel Ltd

3.20%

BlackRock Institutional Trust Company, N.A.

2.89%

Menora Mivtachim Insurance Ltd.

2.47%

Other

81.42%

股东类型

股东统计

占比

Investment Advisor

25.91%

Investment Advisor/Hedge Fund

13.09%

Hedge Fund

12.84%

Insurance Company

4.75%

Research Firm

2.36%

Pension Fund

1.85%

Bank and Trust

0.94%

Family Office

0.81%

Sovereign Wealth Fund

0.20%

Other

37.25%

机构持股

更新时间: 1月20日周一

报告期

机构数

持股数

持股占比

持股变动

2025Q1

1071

683.47M

59.65%

-18.19M

2024Q4

1087

683.52M

59.66%

-22.86M

2024Q3

1029

663.95M

58.60%

-6.13M

2024Q2

1002

631.05M

55.72%

-26.20M

2024Q1

950

595.83M

53.15%

-34.73M

2023Q4

932

601.27M

53.63%

+7.51M

2023Q3

929

573.53M

51.16%

-84.22M

2023Q2

921

512.98M

45.79%

-122.32M

2023Q1

927

576.84M

51.93%

-50.26M

2022Q4

946

573.39M

51.61%

-69.40M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

Fidelity Management & Research Company LLC

76.01M

6.63%

+14.91M

+24.41%

Dec 31, 2024

Clal Insurance Enterprises Holdings Ltd.

38.96M

3.4%

+4.42M

+12.79%

Dec 31, 2024

Ion Asset Management Israel Ltd

36.65M

3.2%

+409.78K

+1.13%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

33.10M

2.89%

+786.74K

+2.43%

Dec 31, 2024

Menora Mivtachim Insurance Ltd.

28.38M

2.48%

-456.80K

-1.58%

Dec 31, 2024

Lingotto Investment Management LLP

27.19M

2.37%

+688.86K

+2.60%

Dec 31, 2024

Migdal Insurance and Financial Holdings Ltd

26.04M

2.27%

+569.41K

+2.24%

Dec 31, 2024

Phoenix Investment and Finances Ltd

21.21M

1.85%

-1.35M

-5.98%

Dec 31, 2024

State Street Global Advisors (US)

19.41M

1.69%

-86.64K

-0.44%

Dec 31, 2024

持股ETF

更新时间: 4月6日周日

机构名称

占比

VanEck Israel ETF

7.39%

iShares MSCI Israel ETF

7.06%

VanEck Pharmaceutical ETF

4.4%

Tema Neuroscience and Mental Health ETF

4.26%

Amplify Weight Loss Drug & Treatment ETF

3.49%

AdvisorShares Dorsey Wright ADR ETF

2.35%

ARK Israel Innovative Technology ETF

1.46%

Amplify International Enhanced Dividend Income ETF

1.33%

FIS Christian Stock Fund ETF

0.91%

Affinity World Leaders Equity ETF

0.9%

VanEck Israel ETF

占比7.39%

iShares MSCI Israel ETF

占比7.06%

VanEck Pharmaceutical ETF

占比4.4%

Tema Neuroscience and Mental Health ETF

占比4.26%

Amplify Weight Loss Drug & Treatment ETF

占比3.49%

AdvisorShares Dorsey Wright ADR ETF

占比2.35%

ARK Israel Innovative Technology ETF

占比1.46%

Amplify International Enhanced Dividend Income ETF

占比1.33%

FIS Christian Stock Fund ETF

占比0.91%

Affinity World Leaders Equity ETF

占比0.9%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

Teva Pharmaceutical Industries Ltd

15.575USD

Teva Pharmaceutical Industries Ltd

15.575

概览

公司